Couragene, Inc.

Edison, NJ

UEI
NEAVP19KF956
CAGE
9EAH5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
46 Dale Dr, Edison, NJ 08820, USA
Website
couragene.com
Founded
2022
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Couragene, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Engineering chemically modified rnps for effective treatment of angelman syndrome - angelman syndrome (as) is a… Grant · R41NS134480 National Institute of Neurological Disorders and Stroke $339,999

Quick answers

What is Couragene, Inc.'s UEI?

Couragene, Inc.'s Unique Entity ID (UEI) in SAM.gov is NEAVP19KF956.

What is Couragene, Inc.'s CAGE code?

Couragene, Inc.'s CAGE code is 9EAH5.

What is Couragene, Inc.'s primary NAICS code?

Couragene, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Couragene, Inc. located?

Couragene, Inc.'s physical address in SAM.gov is 46 Dale Dr, Edison, NJ 08820, USA.

Is Couragene, Inc. registered in SAM.gov?

Couragene, Inc.'s SAM.gov registration expired on August 26, 2026.

What is Couragene, Inc.'s most recent federal award?

Couragene, Inc.'s most recent federal grant award is Engineering chemically modified rnps for effective treatment of angelman syndrome - angelman syndrome (as) is a… (R41NS134480), from National Institute of Neurological Disorders and Stroke, on September 20, 2024.

On GovTribe

See Couragene, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors